MyFinsight

HomeBlogAbout

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

NRX Pharmaceuticals, Inc. (NRXP)

NRX Pharmaceuticals, Inc. (NRXP)

|||

Balance Sheets Overview

Current Ratio
86.08%
Quick Ratio
86.08%
Cash Ratio
78.78%
Debt to Asset Ratio
100.50%
Unit: Thousand (K) dollars
Assets Breakdown
    • Cash and cash equivalents
    • Goodwill (provisional)
    • Intangible assets, net (provisio...
    • Others
Liabilities Breakdown
    • Accumulated deficit
    • Additional paid-in capital
    • Warrant liabilities
    • Others
Balance Sheets
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Cash and cash equivalents
26,686
6,713
7,797
7,184
Accounts receivable, net
206
181
161
239
Prepaid expense and other current assets
2,266
467
934
1,437
Subscription receivable
-
-
-
3,087
Total current assets
29,158
7,361
8,892
11,947
Investments
402
399
397
-
Ppe
-
-
93
93
Nrx Segment
-
-
23
23
Dura Segment
-
-
7
1
Ppe
990
306
-
-
Less accumulated depreciation
71
47
30
24
Property and equipment, net
919
259
63
69
Right-of-use assets, net-Nonrelated Party
665
743
414
107
Right-of-use assets, net-Related Party
167
193
219
243
Intangible assets, net (provisional)
832
879
925
1,777
Goodwill (provisional)
1,793
1,793
1,793
610
Other assets
224
276
253
243
Total assets
34,160
11,903
12,956
14,996
Accounts payable
3,146
4,399
4,270
4,257
Accrued and other current liabilities
11,048
11,280
11,337
9,875
Accrued clinical site costs
340
340
351
351
Convertible note payable and accrued interest, current
-
-
0
9,909
Insurance loan payable
412
-
0
152
Warrant liabilities
18,550
8,766
12,304
15,860
Lease liability, short term-Nonrelated Party
267
283
211
87
Lease liability, short term-Related Party
111
108
105
102
Total current liabilities
33,874
25,176
28,578
40,593
Convertible note payable and accrued interest, long term
-
-
0
0
Lease liability, noncurrent-Nonrelated Party
396
455
199
15
Lease liability, noncurrent-Related Party
60
88
116
143
Total liabilities
34,330
25,719
28,893
40,751
Preferred stock-Nondesignated Preferred Stock
0
0
0
0
Preferred stock-Series AConvertible Preferred Stock
0
0
0
0
Common stock, 0.001 par value, 500,000,000 shares authorized 43,157,744 and 31,734,333 shares issued and outstanding as of june 30, 2026 and december 31, 2025, respectively
43
33
32
28
Additional paid-in capital
324,632
294,476
290,926
281,473
Accumulated deficit
-324,845
-308,325
-306,895
-307,256
Total stockholders deficit
-170
-13,816
-15,937
-25,755
Total liabilities and stockholders' deficit
34,160
11,903
12,956
14,996
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Cash and cashequivalents$26,686K (817.04%↑ Y/Y)Prepaid expense andother current assets$2,266K (34.88%↑ Y/Y)Accounts receivable, net$206K Ppe$990K Total current assets$29,158K (535.25%↑ Y/Y)Goodwill (provisional)$1,793K Property and equipment,net$919K Intangible assets, net(provisional)$832K Right-of-use assets,net-Nonrelated Party$665K Investments$402K Other assets$224K (-9.68%↓ Y/Y)Right-of-use assets,net-Related Party$167K Less accumulateddepreciation$71K Total assets$34,160K (606.08%↑ Y/Y)Accumulated deficit-$324,845K (-7.79%↓ Y/Y)Total liabilities andstockholders' deficit$34,160K (606.08%↑ Y/Y)Total stockholdersdeficit-$170K (99.52%↑ Y/Y)Additional paid-in capital$324,632K (22.17%↑ Y/Y)Common stock, 0.001 parvalue, 500,000,000...$43K (126.32%↑ Y/Y)Total liabilities$34,330K (-15.14%↓ Y/Y)Total currentliabilities$33,874K (-16.26%↓ Y/Y)Lease liability,noncurrent-Nonrelated Party$396K Lease liability,noncurrent-Related Party$60K Warrant liabilities$18,550K (14.04%↑ Y/Y)Accrued and othercurrent liabilities$11,048K (10.77%↑ Y/Y)Accounts payable$3,146K (-13.33%↓ Y/Y)Insurance loan payable$412K (8.99%↑ Y/Y)Accrued clinical sitecosts$340K (-3.13%↓ Y/Y)Lease liability,short...$267K Lease liability,short term-Related...$111K